tm logo
Dead/Abandoned
ABANDONED - NO STATEMENT OF USE FILED

no statement of use filed

on 26 Aug 2024

Last Applicant/ Owned by

12 Gill Street, Suite 4650

Woburn

MA

01801

Serial Number

97256639 filed on 07th Feb 2022

Registration Number

N/A

Correspondent Address

Aaron D. Hendelman

Aaron D. Hendelman Wilson Sonsini Goodrich & Rosati

Palo Alto, CA 94304-1050

UNITED STATES

Filing Basis

1. intent to use

2. intent to use current

Disclaimer

NO DATA

Logo Mark Trademark Information

Scientific design and development of excipients and formulations for use with therapeutic biologics; scientific research and design in the field of therapeutic formulation development; consulting in the fields of therapeutic formulation and excipient development; chemical engineering in the nature of formulation and reformulation of therapeutic compositions Licensing of intellectual property Bio Read More

Classification Information


Class [045]
Personal & Legal & Social Services


Licensing of intellectual property


First Use Date in General

N/A

First Use Date in Commerce

N/A

Class [042]
Computer & Software Services & Scientific Services


Scientific design and development of excipients and formulations for use with therapeutic biologics; scientific research and design in the field of therapeutic formulation development; consulting in the fields of therapeutic formulation and excipient development; chemical engineering in the nature of formulation and reformulation of therapeutic compositions


First Use Date in General

N/A

First Use Date in Commerce

N/A

Class [005]
Pharmaceutical Products


Biologic medicines for medical diagnosis and treatment, namely, pharmaceutical preparations for the treatment of symptoms in oncology, immunology, inflammation, dermatology, hematology, gastroenterology, cardiovascular, respiratory and infectious diseases; monoclonal antibodies and therapeutic proteins for medical diagnosis and treatment; drug delivery apparatus in the form of a prefilled syringe, prefilled pen, on-body wearable medication delivery device in the nature of a device attached to the body for subcutaneous or transdermal medication delivery, subcutaneous infusion pump and vial containing a liquid or frozen solution solution for reconstitution or dilution prior to administration, all of the foregoing sold prefilled with biologic medicines and therapeutic compositions that facilitate the delivery of pharmaceutical preparations for the treatment of symptoms in oncology, immunology, inflammation, dermatology, hematology, gastroenterology, cardiovascular, respiratory and infectious diseases


First Use Date in General

N/A

First Use Date in Commerce

N/A

Class [040]
Treatment & Processing of Materials Services


Manufacturing, processing, and treating the therapeutic molecules of others; processing the therapeutic molecules of others


First Use Date in General

N/A

First Use Date in Commerce

N/A

Mark Details


Serial Number

No 97256639

Mark Type

No Service Mark

Attorney Docket Number

No 64327-TM1001

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Design Code(s)

02.01.33 -

Grotesque men formed by letters, numbers, punctuation or geometric shapes

04.07.03 -

Geometric figures or combinations of geometric figures representing a person

26.01.02 -

Plain single line circles

26.01.21 -

Circles that are totally or partially shaded

26.17.09 -

Curved line(s), band(s) or bar(s)

26.17.12 -

Chevrons and angles

Legal History


Show more

Status DateAction Taken
26th Aug 2024ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
26th Aug 2024ABANDONMENT - NO USE STATEMENT FILED
23rd Jan 2024NOA E-MAILED - SOU REQUIRED FROM APPLICANT
28th Nov 2023OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
28th Nov 2023PUBLISHED FOR OPPOSITION
08th Nov 2023NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
25th Oct 2023APPROVED FOR PUB - PRINCIPAL REGISTER
11th Oct 2023EXAMINER'S AMENDMENT ENTERED
11th Oct 2023NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
11th Oct 2023EXAMINERS AMENDMENT E-MAILED